Home › Dermatite atopica (eczema) › California › Los Angeles
Studi clinici su Dermatite atopica (eczema) a Los Angeles, CA
11 studi su Dermatite atopica (eczema) cercano partecipanti presso sedi a Los Angeles e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
In reclutamentoStudio osservazionale
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
In reclutamentoFase 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
In reclutamentoFase 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
In reclutamentoFase 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
In reclutamentoFase 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
In reclutamentoFase 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
In reclutamentoStudio osservazionale
- Galderma Investigational Site 7099, Los Angeles
Studi su Dermatite atopica (eczema) in altre città
- New York City, NY13 studi
- Washington, DC11 studi
- San Antonio, TX10 studi
- San Diego, CA10 studi
- Birmingham, AL9 studi
- Miami, FL9 studi
- Dallas, TX8 studi
- Huntington Beach, CA8 studi
- Sacramento, CA8 studi
- Troy, MI8 studi
- Indianapolis, IN7 studi
- Pittsburgh, PA7 studi
Altri studi a Los Angeles
- Cancro del polmone non a piccole cellule87 studi
- Cancro (tutti i tipi)74 studi
- Cancro al seno73 studi
- Cancro alla prostata61 studi
- Cancro colorettale59 studi
- Cancro metastatico57 studi
- Cancro ovarico50 studi
- Cancro ai polmoni45 studi
- Carcinoma a cellule squamose della testa e del collo42 studi
- Cancro pancreatico35 studi
- Cancro dell'endometrio34 studi
- Melanoma34 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.